Gastric Cancer Subtypes in Tumour and Nontumour Tissues by Immunologic and Hallmark Gene Sets

Abstract

A previous research study on differentiating gastric cancer (GC) into distinct subtypes or prognostic models was mostly based on GC tissues, which neglected the role of nontumour tissues in GC subtypes. The purpose of the research was to identify GC subtypes on the basis of tumour and adjacent nontumour tissues to assess the prognosis of GC patients. We characterized three GC subtypes on the basis of the immunologic and hallmark gene sets in GC and adjacent nontumour tissues: among them, the GC patients with subtype I had the longest survival time compared to patients with other subtypes. The classification was closely associated with T stage and pathological stage of GC patients. A prognostic model containing two gene sets was constructed by LASSO analysis. Kaplan–Meier analysis showed that patients in the high-risk group survived longer than those in the low-risk group and the two prognostic genes sets in the model were strongly correlated with survival status. Then, GO and KEGG analyses and PPI network show that nontumour and tumour tissues are influencing the prognosis of GC patients in separate manners. In summary, we emphasized the prognostic value of nontumour tissue in GC patients and proposed a novel insight that both changes in tumour and nontumour tissues should be taken into account when selecting a treatment strategy for GC.

Integrated oxidative stress score for predicting prognosis in stage III gastric cancer undergoing surgery

“…Gastric cancer ranked sixth among the global cancer burdens in both females and males in 2020, and remains one of the prime causes of cancer-related morbidity and cancer-related death in the world [1,2]. The incidence of gastric cancer is highest in Eastern Asia, such as South Korea and China, and is largely dependent on Helicobacter pylori infection, co-infection by Epstein-Barr virus (EBV), gastroesophageal reflux disease, and obesity [3,4].…”